Unravelling the Antifibrinolytic Mechanism of Action of the 1,2,3-Triazole Derivatives
A new family of antifibrinolytic drugs has been recently discovered, combining a triazole moiety, an oxadiazolone, and a terminal amine. Two of the molecules of this family have shown activity that is greater than or similar to that of tranexamic acid (TXA), the current antifibrinolytic gold standar...
Main Authors: | Rabadà, Yvette, Bosch-Sanz, Oriol, Biarnés, Xevi, Pedreño, Javier, Caveda, Luis, Sánchez-García, David, Martorell, Jordi, Balcells, Mercedes |
---|---|
Other Authors: | Massachusetts Institute of Technology. Institute for Medical Engineering & Science |
Format: | Article |
Published: |
MDPI AG
2024
|
Online Access: | https://hdl.handle.net/1721.1/155685 |
Similar Items
-
Optimization of 3D autologous chondrocyte-seeded polyglycolic acid scaffolds to mimic human ear cartilage
by: Melgar-Lesmes, Pedro, et al.
Published: (2024) -
FSW TESTING123
by: TESTING123
Published: (2020) -
Synthesis and extended activity of triazole-containing macrocyclic protease inhibitors
by: Pehere, Ashok D., et al.
Published: (2014) -
Toughening of epoxies by covalently anchoring triazole-functionalized stacked-cup carbon nanofibers
by: Ding, Guoqiang, et al.
Published: (2013) -
Discovery of novel triazole-containing pyrazole ester derivatives as potential antibacterial agents
by: Chu, Ming-Jie, et al.
Published: (2019)